Alopecia associated with strontium ranelate use in a 62-year-old woman

作者：Lee Y Y; Yang C H; Chen C H; Hwang J S^*

来源：Osteoporosis International, 2013, 24(3): 1127-1129.

DOI：10.1007/s00198-012-1979-9

• Alopecia
• Anagen effluvium
• Strontium ranelate

Strontium ranelate is an effective drug that was developed for treating osteoporosis. Here, we report the case of a 62-year-old woman who developed headache and diffuse scalp hair loss 1 week after receiving strontium ranelate treatment for osteoporosis. The treatment was subsequently stopped because of the intractable headache. Nevertheless, the patient continued to lose hair for 6 weeks following treatment discontinuation. Histopathological analysis of scalp tissues revealed anagen effluvium. The patient%26apos;s hair started regrowing slowly 2 months after treatment with strontium ranelate was discontinued.

• 出版日期2013-3
• 单位长春大学